Bauke Kogelman1, Margriet Hulsker2, Christa Tanganyika-de Winter2, Ralf Werring2, Annemieke Aartsma-Rus2, Maaike van Putten2, and Louise van der Weerd1,2
1Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands
Synopsis
Duchenne
muscular dystrophy is affecting skeletal and cardiac muscle tissue, due to
non-functional dystrophin protein. Potential therapies restore dystrophin
expression in skeletal muscle, while cardiac muscle is more difficult to
target. To elucidate whether exercise is beneficial or disadvantageous for
(cardio)myopathy, we subjected several mouse models, mdx (0% dystrophin), mdx-Xist∆hs
(varying dystrophin levels), Bl10-WT and Xist-WT wild type mice (100%
dystrophin) to low intensity or no exercise. Results showed that low dystrophin
levels improve skeletal muscle and cardiac function and suggest that low
intensity exercise is beneficial for skeletal and cardiac muscle function in both
dystrophic and wild type mice. Purpose
Duchenne muscular dystrophy (DMD) patients suffer from
a genetic mutation preventing synthesis of functional dystrophin proteins. In
absence of dystrophin, muscle fibers are prone to injury leading to severe
muscle weakness and wheelchair dependency. Ultimately due to cardiorespiratory
failure DMD patients die between the 2nd and 4th decade
of life (1–3). There are several therapeutic approaches resulting
in dystrophin restoration in skeletal muscle, while cardiac myocytes are more
difficult to target. Dystrophin restoring therapies aim to improve muscle
function, leading to increased physical activity and thus to increased cardiac workload,
thereby potentially affecting (cardio)myopathy. There are two hypotheses on the
effect of exercise on disease progression in DMD, 1: “Use it or lose it”: a
beneficial relation between exercise and heart and muscle function, and 2: “Use
it and lose it”: increased muscle and cardiac workload accelerates (cardio)myopathy. Therefore, we studied the effect of low intensity exercise on
skeletal muscle and cardiac function in DMD mouse models expressing varying
dystrophin levels.
Methods
We subjected 15.5 month old female
mdx-
Xist∆hs mice expressing low
dystrophin levels based on non-random X-inactivation (quadriceps: 3-40%, heart:
3-14%, n=28),
C57Bl/10ScSn-mdx/J (
mdx) (0% dystrophin, n=8),
and their respective wild type strains C57BL/10ScSnJ (Bl10-WT, n=8) and
Xist∆hs (
Xist-WT, n=8) to voluntary wheel running or no exercise for a
period of two months. Mice were housed in individual cages containing a running
wheel for eight sessions of 3-4 days for 28 days. Thereafter, muscle function
was assessed in a two-week functional test regime consisting of grid and wire
hanging tests. At the age of 18 months, a MRI scan was acquired to assess
cardiac function. Mice were scanned on a 7 Tesla Bruker Pharmascan with
ParaVision 5.1. A retrospective Intragrate FLASH sequence was used to
acquire short-axis images, with FA=18°, TE=1.7ms, TR=6ms, FOV=3.4x3.4cm, matrix=256x144,
repetitions=256 and 8-9 slices. Images were segmented using MASS for Mice (4) to calculate ejection fraction (EF), stroke volume,
cardiac output (CO) and end-diastolic volume of the left and right ventricles.
All cardiac parameters were normalized to body mass. Cardiac data presented
here are only incomplete for the
mdx-
Xist∆hs mice (n=10 instead of 28).
Fibrosis of the quadriceps and heart was assessed by histological assessments
and dystrophin levels of the
mdx-
Xist∆hs mice by Western blot.
Results
Mdx mice ran
6.7 km, mdx-Xist∆hs
9.4 km and Bl10-WT and Xist-WT wild-type
mice 10.1 and 14.3 km respectively per night on the voluntary wheel (figure
1). Muscle function was impaired in mdx mice, but improved for both hanging
tests in mdx-Xist∆hs mice. Voluntary
wheel exercise improved hanging performance in all strains (figure 2). Fibrosis
of the quadriceps was pronounced in mdx mice, while it partly normalized
to wild type levels in mdx-Xist∆hs mice. Voluntary
wheel exercise did not exacerbate fibrosis.
Cardiac
hypertrophy, determined by heart-to-body
mass ratio, was only observed in mdx
mice, but not in mdx-Xist∆hs or wild type mice and was not affected by the exercise
regime (figure 3). EF and CO were reduced in mdx mice compared to Bl10-WT mice. Low amounts of dystrophin
(3-14%) in the mdx-Xist∆hs mice improved
EF and CO compared to mdx mice. Collagen
infiltration was highest in mdx mice,
less pronounced in mdx-Xist∆hs
mice and did not increase upon exercise in any of the strains.
Exercise improved CO in all
strains, but CO was still reduced in mdx mice. In mdx-Xist∆hs mice, exercise renormalized
CO to wild type levels and the amount of voluntary exercise for this group was
similar to their WT controls (figure 1+4).
Discussion
Low amounts of dystrophin
improved muscle function assessed with hanging tests and decreased muscle
pathology in the aged mdx-Xist∆hs mice. This is in line with previous reports in young mdx-Xist∆hs mice (5). The increased cardiac workload improved CO in all
strains, even in the mdx mice, where
cardiac function is already compromised by phenotype. Cardiomyopathy did not
deteriorate further between the age of 10 and 18 months in mdx mice (6).
We observed a significant strain
effect, with mice on a Bl6/Bl10 (mdx-Xist∆hs and Xist-WT mice) background exercising much less than mice on a
Bl10 background. These strain differences may have had an effect on the disease
progression of the mdx-Xist∆hs mice due
to the intrinsic behavioral differences between the backgrounds.
Conclusion
These results show that low dystrophin levels
improve skeletal muscle and cardiac function and suggest that low intensity
exercise is beneficial for both cardiac and muscle function in both dystrophic
and wild type mice.
Acknowledgements
No acknowledgement found.References
1. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe
L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1:
diagnosis, and pharmacological and psychosocial management. Lancet Neurol
[Internet]. Elsevier Ltd; 2010;9(1):77–93. Available from:
http://dx.doi.org/10.1016/S1474-4422(09)70271-6
2. Moser H.
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum
Genet [Internet]. 1984;66(1):17–40. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/6365739
3. Kohler M,
Clarenbach CF, Böni L, Brack T, Russi EW, Bloch KE. Quality of Life, Physical
Disability, and Respiratory Impairment in Duchenne Muscular Dystrophy. Am J
Respir Crit Care Med [Internet]. 2005;172(8):1032–6. Available from:
http://www.atsjournals.org/doi/abs/10.1164/rccm.200503-322OC 4
4.
Van Der Geest RJ, Reiber JHC. Quantification in
cardiac MRI. J Magn Reson Imaging. 1999;10:602–8.
5.
van Putten M, Hulsker M,
Nadarajah VD, van Heiningen SH, van Huizen E, van Iterson M, et al. The effects of low
levels of dystrophin on mouse muscle function and pathology. PLoS One
[Internet]. 2012 Jan [cited 2014 Apr 3];7(2):e31937. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3281102&tool=pmcentrez&rendertype=abstract
6. van Putten
M, van der Pijl EM, Hulsker M, Verhaart IEC, Nadarajah VD, van der Weerd L, et
al. Low dystrophin levels in heart can delay heart failure in mdx mice. J Mol
Cell Cardiol [Internet]. The Authors.; 2014 Apr [cited 2014 Nov 19];69:17–23.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24486194